Panel Discussion

Sunday, March 10, 2024

5:36 PM – 5:51 PM ET

Panel Moderator(s)

Tarek Helmy, MD, FACC, MSCAI

Chief of Cardiology and Director of Cardiac Cath Lab
Ochsner LSU
Shreveport, Louisiana, United States

Disclosure information not submitted.
Stephane Rinfret, MD, SM

Director of Complex Coronary Interventions
Georgia Heart Institute
Gainesville, Georgia, United States

Disclosure information not submitted.
Jason Wollmuth, MD

Interventional Cardiologist
Providence Heart and Vascular Institute
Portland, Oregon, United States

Disclosure information not submitted.

Panel Discussant(s)

Florim Cuculi, MD

Head of Cardiology
Heart Center Lucerne, Luzern, Switzerland

Disclosure information not submitted.
Debabrata Dash, MD, DM, FICC, FSCAI, FAPSC, FCCP, FACC, FESC

Consultant Interventional Cardiologist
Aster Hospital, Al Mankhool Dubai, UAE
Dubai, Dubai, United Arab Emirates

No relationships to disclose
Farouc A. Jaffer, MD, PhD

Director Coronary Intervention and CTO PCI Program
Massachusetts General Hospital / Harvard Medical School
Boston, Massachusetts, United States

Disclosure(s): Canon, HeartFlow, Siemens, Mercator, Amarin, Neovasc, Teleflex: University Grants/Research Support (Ongoing); DurVena Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Intravascular Imaging Incorporated: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Massachusetts General Hospital: Receipt of Royalties (Ongoing); Medtronic, Fastwave, Intravascular Imaging Inc, Saghmos, DurVena: Consultant (Ongoing)
Allen Jeremias, MD, FSCAI

Associate Director, Cardiac Cath Lab
St. Francis Hospital, Roslyn, NY
Woodbury, New York, United States

No relationships to disclose
Jaikirshan Khatri, MD

Director of Complex Coronary Intervention
Cleveland Clinic
Cleveland, Ohio, United States

Disclosure information not submitted.
Gautam Kumar, MD, FSCAI

Professor
Emory University / Atlanta VA Medical Center
Atlanta, Georgia, United States

Disclosure(s): 2MG Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Ablative Solutions, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Cardio Flow Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Efemoral Medical, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Fastwave: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Vantis Vascular, Inc.: Advisory Committee/Board Member (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Rajesh Sachdeva, MD

Professor of Medicine
Atlanta VA Medical Center, Georgia, United States

No relationships to disclose
Gerald S. Werner, MD, PhD, FSCAI

Director
Klinikum Darmstadt GmbH
Darmstadt, Hessen, Germany

Disclosure information not submitted.
Masahisa Yamane, MD

Senior Advisor
Saitama Sekishinkai Hospital
Tokyo, Tokyo, Japan

No relationships to disclose